Search research articles
Contact Us
Filters
Showing results (321-330 of 476) with videos related to
Page
of 48
Sort By:
Cancer Research
|
April 16, 2009
PIK3CA and PIK3CB inhibition produce synthetic lethality when combined with estrogen deprivation in estrogen receptor-positive breast cancer
Robert J Crowder, Chanpheng Phommaly, Yu Tao, et al.
ESMO Open
|
April 19, 2023
Prognostic value of intrinsic subtypes in hormone-receptor-positive metastatic breast cancer: systematic review and meta-analysis
F Schettini, O Martínez-Sáez, C Falato, et al.
BMC Medical Genomics
|
November 3, 2011
Gene expression profiles of breast biopsies from healthy women identify a group with claudin-low features
Vilde D Haakensen, Ole Christian Lingjaerde, Torben Lüders, et al.
BMC Bioinformatics
|
January 30, 2020
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: comparison of gene expression profiling approaches
Arran K Turnbull, Cigdem Selli, Carlos Martinez-Perez, et al.
Breast Cancer Research and Treatment
|
February 25, 2016
Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-study
Miguel Martin, Jan C Brase, Amparo Ruiz, et al.
Bioengineering & Translational Medicine
|
November 18, 2024
Combination of polymeric micelle formulation of TGFβ receptor inhibitors and paclitaxel produces consistent response across different mouse models of Triple-negative breast cancer
Natasha Vinod, Duhyeong Hwang, Sloane Christian Fussell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 6, 2014
Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance)
William M Sikov, Donald A Berry, Charles M Perou, et al.
Nature Communications
|
January 24, 2013
MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11
Jessica Bockhorn, Rachel Dalton, Chika Nwachukwu, et al.
Biorxiv : the Preprint Server for Biology
|
March 16, 2026
Transcriptomic profiling of mouse mammary tumors enables prognostic and predictive biomarker discovery for human breast cancers
Matthew D Sutcliffe, Kevin R Mott, Tulay Yilmaz-Swenson, et al.
ESMO Open
|
March 5, 2024
Prognostic value of HER2DX in early-stage HER2-positive breast cancer: a comprehensive analysis of 757 patients in the Sweden Cancerome Analysis Network-Breast dataset (SCAN-B)
G Villacampa, T Pascual, F Brasó-Maristany, et al.
Page
of 48
Search research articles
Search
Showing results (321-330 of 476) with videos related to
Sort By:
Page
of 48
Cancer Research
|
April 16, 2009
PIK3CA and PIK3CB inhibition produce synthetic lethality when combined with estrogen deprivation in estrogen receptor-positive breast cancer
Robert J Crowder, Chanpheng Phommaly, Yu Tao, et al.
ESMO Open
|
April 19, 2023
Prognostic value of intrinsic subtypes in hormone-receptor-positive metastatic breast cancer: systematic review and meta-analysis
F Schettini, O Martínez-Sáez, C Falato, et al.
BMC Medical Genomics
|
November 3, 2011
Gene expression profiles of breast biopsies from healthy women identify a group with claudin-low features
Vilde D Haakensen, Ole Christian Lingjaerde, Torben Lüders, et al.
BMC Bioinformatics
|
January 30, 2020
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: comparison of gene expression profiling approaches
Arran K Turnbull, Cigdem Selli, Carlos Martinez-Perez, et al.
Breast Cancer Research and Treatment
|
February 25, 2016
Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-study
Miguel Martin, Jan C Brase, Amparo Ruiz, et al.
Bioengineering & Translational Medicine
|
November 18, 2024
Combination of polymeric micelle formulation of TGFβ receptor inhibitors and paclitaxel produces consistent response across different mouse models of Triple-negative breast cancer
Natasha Vinod, Duhyeong Hwang, Sloane Christian Fussell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 6, 2014
Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance)
William M Sikov, Donald A Berry, Charles M Perou, et al.
Nature Communications
|
January 24, 2013
MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11
Jessica Bockhorn, Rachel Dalton, Chika Nwachukwu, et al.
Biorxiv : the Preprint Server for Biology
|
March 16, 2026
Transcriptomic profiling of mouse mammary tumors enables prognostic and predictive biomarker discovery for human breast cancers
Matthew D Sutcliffe, Kevin R Mott, Tulay Yilmaz-Swenson, et al.
ESMO Open
|
March 5, 2024
Prognostic value of HER2DX in early-stage HER2-positive breast cancer: a comprehensive analysis of 757 patients in the Sweden Cancerome Analysis Network-Breast dataset (SCAN-B)
G Villacampa, T Pascual, F Brasó-Maristany, et al.
Page
of 48